Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2079446 Title: PALIPERIDON DUURZAME AFGIFTEFORMULERING

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
087955415
WO application number:
US2008010014
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2079446
WO publication number:
WO 2009/025859
1rst applicant's nationality:
Translation language:
Dutch
EPO publication language:
English
SPC number:

Dates

Filing date:
21/08/2008
Grant date:
26/10/2011
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
10/01/2012
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
26/10/2011
EP B1 publication date:
26/10/2011
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/08/2014
Expiration date (if granted and all annual fees paid):
21/08/2028

Applicant

Name:
Teva Pharmaceutical Industries Ltd.
Legal Form:
From:
26/10/2011
Address:
5 Basel Street P.O. Box 3190, 49131 Petah Tiqva, Israel (IL)
To:

Agent

1

Name:
VAN KOOIJ Adriaan
Legal Form:
From:
23/05/2019
Address:
Bezuidenhoutseweg 57, 2594 AC, DEN HAAG, Netherlands (NL)
To:

2

Name:
VAN KOOIJ Adriaan
Legal Form:
From:
10/01/2012
Address:
Bezuidenhoutseweg 57, 2594 AC, DEN HAAG, Netherlands (NL)
To:
23/05/2019

Inventor

1

Name:
FOX, Michael
Legal Form:
Address:

2

Name:
DI CAPUA, Simona
Legal Form:
Address:

3

Name:
REINBERG, Ronny
Legal Form:
Address:

Priority

Priority patent number:
935597
Priority date:
21/08/2007
Priority country:
United States (US)

Classification

Main IPC class:
A61K 9/16;
IPC or IDT classification:
A61K 9/20; A61K 9/50;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2011/10
Publication date:
31/10/2011
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2015/02
Publication date:
16/09/2019
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
23/08/2013
Last annual fee paid number:
6
Last annual fee paid amount:
85 Euro
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
10/01/2012 General Document (F - F:Traduction déposée par fax) 34 PDF /6/4/4/9/7/0612079446/migrated-docs/087955415_1_286420.pdf
12/01/2012 General Document (OF - T:Traduction Originale de la traduction déposée par fax) 35 PDF /6/4/4/9/7/0612079446/migrated-docs/087955415_2_286420.pdf